🇺🇸 IMOJEV in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 10

Most-reported reactions

1. Acute Kidney Injury — 1 report (10%)
2. Anuria — 1 report (10%)
3. Cerebral Haemorrhage — 1 report (10%)
4. Diarrhoea — 1 report (10%)
5. Influenza Like Illness — 1 report (10%)
6. Lactic Acidosis — 1 report (10%)
7. Nephrotic Syndrome — 1 report (10%)
8. Oliguria — 1 report (10%)
9. Pneumonia — 1 report (10%)
10. Vomiting — 1 report (10%)

Source database →

Frequently asked questions

Is IMOJEV approved in United States?

IMOJEV does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for IMOJEV in United States?

SK Bioscience Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.